Bexxar

tositumomab

CD20 monoclonal antibodies

Therapeutic radiopharmaceuticals

Scoring is done by our AI based assistant on the data from the FDA and other sources

6.7

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

By Action

7.4

Kesimpta

7.4

Epcoritamab-bysp (Subcutaneous)

7.4

Briumvi

6.9

Columvi

6.7

Epkinly

6.7

Rituxan

7.7

Sodium phosphate p 32 (Intravenous)

7.7

Chromic phosphate p 32 (Injection)

7.5

Sodium iodide i 131 (Oral)

7.4

Iodotope (Oral)

7.4

Xofigo

7.1

Pluvicto